Objectiveto evaluate the efficacy of octreotide for use in patients with postoperative chyle fistulas. Chyle leak can lead to a systemic metabolic imbalance, a prolonged wound healing and longer hospital stay Conclusion octreotide therapy with primary treatment is an effective way of stopping chyle leak in neck dissection
Use of Octreotide for the Management of Chyle Fistula Following Neck
Many patients with medical reasons for their chylothorax and postoperative patients with chyle leaks due to minor trauma to the main thoracic duct or disruptions of thoracic duct tributaries fall into this category.
Chyle leak is a rare complication following otolaryngologic, thoracic, and trauma surgery wherein the thoracic duct is transected
Case reports and small case series describe octreotide for the medical management of chyle leak, but limited data exist to determine the ideal dose. Octreotide therapy, a synthetic hormone similar to somatostatin, has emerged as a viable treatment option for chyle leak management Octreotide works by reducing the production and flow of chyle, helping alleviate symptoms and promoting the healing process Postoperative chyle leak is a rare but serious complication of head and neck surgery
